Client Reviews
Not yet reviewed
No professional misconduct found.
Overview
Practice Areas
|
-
80% Business
-
20% Intellectual Property
|
Contact Information
|
|
References
Client Reviews
|
How would you rate this lawyer?
If you're a current or former client, share your thoughts (anonymously, if you prefer). Would you recommend this lawyer to other clients?
Review this lawyer
|
Peer Endorsements
|
Endorse a fellow lawyer, get more visits to your profile
In addition to providing a simple way to express your gratitude to fellow lawyers, any time you add an endorsement to a peer's profile, a link to your profile will appear on it.
Endorse this lawyer
|
Résumé
License
|
18 years since Eileen Smith Ewing was first licensed to practice law.
| State |
License status |
Year acquired |
Last updated by Avvo |
| Massachusetts |
Active
|
1993 |
01/29/2012 |
We have not found any instances of professional misconduct for this lawyer.
|
Education
|
| School |
Major |
Degree |
Graduated |
| Columbia University School of Law |
Law |
JD - Juris Doctor |
1989 |
| Columbia University |
Japanese Intellectual History |
M.Phil. |
1989 |
| Columbia University |
Japanese Intellectual History |
MA - Masters |
1989 |
| Harvard University |
|
AB |
1984 |
See all 4 degrees
|
Associations
|
| Position |
Association Name |
Duration |
| Chair |
American Bar Association, Biotechnology Committee |
|
| Member |
Massachusetts Bar Association |
|
| Member |
New York State Bar Association |
|
| Secretary |
Women Executives Advancing Life Sciences, Technology and Healthcare |
|
| Board Member |
Women Executives Advancing Life Sciences, Technology and Healthcare |
|
See all 5 association entries
|
Portfolio
Publications
|
| Article |
Publication |
Date |
| The Science of the Deal: Handling Transactions for Life Sciences Clients |
in Inside the Minds: Winning Legal Strategies for Life Sciences Settlements and Negotiations, Aspatore Press |
2006 |
| Biotech's Industrial 'Third Wave': Finally, a Chance to Generate Revenue |
Mass High Tech |
2005 |
| Surgery Breathes New Life into Biotech |
Venture Capital Journal |
2005 |
| Biotech-Device Convergence Brings Its Own Business Issues |
Mass High Tech |
2004 |
| VC and Big Pharma; Biotech’s Dysfunctional Parents Find Value in Working Things Out |
Venture Capital Journal |
2004 |
See all 5 publications
|
Speaking Engagements
|
| Presentation Name |
Conference |
Date |
| Corporate Partnering: Deals that Are ‘Fueling’ the Industrial Biotech Revolution |
ALI-ABA Emerging Issues in Biotechnology Conference |
2007 |
| Collaborations: The Cornerstone of the Biotechnology Industry’s Future |
Annual Meeting of the Massachusetts Biotechnology Council |
2005 |
| Cross-Border Biotechnology Transactions: Strategic Intellectual Property and Regulatory Considerations |
Annual Meeting of the American Bar Association, Section of Science & Technology Law, Biotechnology Committee |
2005 |
| Strategic Alliances with Big Pharma: An Early Source of Capital |
Annual Meeting of the American Bar Association, Section of Science & Technology Law, Biotechnology Committee |
2004 |
| Privacy Legislation and Biotechnology |
Biotech Law & Litigation Summit |
2001 |
See all 5 speaking engagements
|
|
